Viewing StudyNCT00062660



Ignite Creation Date: 2024-05-05 @ 11:30 AM
Last Modification Date: 2024-10-26 @ 9:08 AM
Study NCT ID: NCT00062660
Status: APPROVED_FOR_MARKETING
Last Update Posted: 2016-11-30
First Post: 2003-06-10

Brief Title: Tipranavir in Patients With Progressive Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection
Sponsor: Boehringer Ingelheim
Organization: Boehringer Ingelheim

Key Dates - Follows AllAPIJSON File Order

Start Date: 2003-05
Start Date Type: None
Primary Completion Date: 2014-04
Primary Completion Date Type: ACTUAL
Completion Date: 2014-04
Completion Date Type: ACTUAL
First Submit Date: 2003-06-10
First Submit QC Date: June 11 2003
Study First Post Date: 2003-06-12
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2016-11-29
Last Update Post Date: 2016-11-30
Last Update Post Date Type: ESTIMATED